Sai Life Sciences IPO Description – Sai Life Sciences is the fastest-growing contract research, development, and manufacturing organization (CRDMO). It is also one of the few CRDMOs to have research laboratories for discovery and development located near overseas innovation hubs at Watertown (Greater Boston, MA), United States (US), and Manchester, United Kingdom (UK), complemented by large-scale research laboratories and manufacturing facilities in cost competitive locations in India.
The company has served more than 280 innovator pharmaceutical companies, including 18 of the top 25 pharmaceutical companies, across regulated markets, including the US, the UK, Europe, and Japan. It also provides CRO services to more than 60 customers on an ongoing basis, for their integrated drug discovery programs. As of 30 September 2024, its CDMO product portfolio included more than 170 innovative pharmaceutical products, including 38 products that were supplied for the manufacturing of 28 commercial drugs.
As of 30 September 2024, the company has 3,135 employees globally, including 2,353 scientific staff, with the majority of the scientific team holding advanced degrees, including 302 PhDs and 1,475 master’s degrees.
Promoters of Sai Life Sciences – Kanumuri Ranga Raju, Krishnam Raju Kanumuri, Kanumuri Mytreyi, Sai Quest Syn Private Limited, Marigold Partners, Sunflower Partners, Tulip Partners and Lily Partners
Table of Contents
Sai Life Sciences IPO Details
| Sai Life Sciences IPO Dates | 11 – 13 December 2024 |
| Sai Life Sciences Issue Price | INR 522 – 549 per share |
| Fresh issue | INR 950 crore |
| Offer For Sale | 3,81,16,934 shares (INR 2,092.62 crore) |
| Total IPO size | INR 3,042.62 crore |
| Minimum bid (lot size) | 27 shares (INR 14,823) |
| Face Value | INR 1 per share |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
Sai Life Sciences Financial Performance
| Â | FY 2022 | FY 2023 | FY 2024 | H1 FY 2025 |
| Revenue | 869.59 | 1,217.14 | 1,465.18 | 675.29 |
| Expenses | 888.05 | 1,228.70 | 1385.04 | 656.09 |
| Net income | 6.23 | 9.99 | 82.81 | 28.01 |
| Margin (%) | 0.72 | 0.82 | 5.65 | 4.15 |
Sai Life Sciences Offer News
- Sai Life Sciences RHP
- Sai Life Sciences DRHP
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Sai Life Sciences Valuations & Margins
| FY 2022 | FY 2023 | FY 2024 (Pre Issue) | FY 2025 (Post-Issue)* | |
| EPS | 0.33 | 0.52 | 4.34 | 2.69 |
| PE Ratio | – | – | 120.2 – 126.41 | 193.8 – 203.82 |
| FY 2022 | FY 2023 | FY 2024 | |
| RONW (%) | 0.71 | 1.13 | 8.50 |
| NAV | 48.90 | 49.18 | 53.83 |
| ROCE (%) | 3.21 | 5.13 | 10.26 |
| EBITDA (%) | 15.07 | 14.97 | 20.48 |
| Debt/Equity | 0.84 | 0.80 | 0.75 |
Sai Life Sciences IPO GMP Today (Daily Trend)
| Date | Day-wise IPO GMP | Kostak | Subject to Sauda |
| 17 December 2024 | 70 | – | 1,800 |
| 16 December 2024 | 42 | – | 1,500 |
| 14 December 2024 | 38 | – | 2,200 |
| 13 December 2024 | 27 | – | 700 |
| 12 December 2024 | 38 | – | 900 |
| 11 December 2024 | 33 | – | 700 |
| 10 December 2024 | 35 | – | 700 |
| 9 December 2024 | 30 | – | 500 |
| 7 December 2024 | 30 | – | – |
Sai Life Sciences IPO Objectives
The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Repayment/ prepayment, in full or part, of all or certain outstanding borrowings availed by the company – INR 720 crore
- General corporate purposes
Sai Life Sciences – Comparison With Listed Peers
| Company | PE ratio | EPS | RONW (%) | NAV | Revenue (Cr.) |
| Sai Life Sciences | 203.82 | 2.69 | 8.50 | 53.83 | 1,465.18 |
| Divi’s Laboratories | 103.04 | 60.27 | 11.79 | 511.21 | 7,845.0 |
| Suven Pharmaceuticals | 109.37 | 11.80 | 14.64 | 94.04 | 1,051.35 |
| Syngene International | 73.59 | 12.71 | 11.98 | 105.91 | 3,488.60 |
Sai Life Sciences IPO Dates & Listing Performance
| IPO Opening Date | 11 December 2024 |
| IPO Closing Date | 13 December 2024 |
| Finalization of Basis of Allotment | 16 December 2024 |
| Initiation of refunds | 17 December 2024 |
| Transfer of shares to demat accounts | 17 December 2024 |
| Sai Life Sciences IPO Listing Date | 18 December 2024 |
| Opening Price on NSE | INR 650 per share (up 18.40%) |
| Closing Price on NSE | INR 764.65 per share (up 39.28%) |
Sai Life Sciences IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Aditya Birla Money – Subscribe for long term
Ajcon Global –
Arihant Capital –
Axis Capital –
Ashika Research –
BP Wealth – Subscribe
Capital Market – Subscribe
Canara Bank Securities – Subscribe
Choice Broking –
Dalal & Broacha –
Elara Capital –
Elite Wealth – Avoid
GCL Broking –
Geojit –
GEPL Capital – Avoid
Hem Securities –
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Investmentz –
Indsec Securities –Â
Jainam Broking – Avoid
KR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Mehta Equities – Subscribe with risk
Nirmal Bang – Subscribe for long term
Reliance Securities –
Sushil Finance –
Samco Securities – Avoid
SBI Securities – Subscribe for long term
SMC Global – 1.5/5
SMIFS –
Systematix Research –
Swastika Investmart – Neutral
Ventura Securities – Avoid
Sai Life Sciences Offer Lead Manager
IIFL SECURITIES LIMITED
24th Floor, One Lodha Place, Senapati Bapat Marg,
Lower Parel (West) Mumbai 400 013 Maharashtra
Phone: Â +91 22 4646 47283
Email:Â [email protected]
Website: www.iiflcap.com
Sai Life Sciences Offer Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel:Â +91 40 6716 2222
E-mail:Â [email protected]
Website:Â www.kfintech.com
Sai Life Sciences Contact Details
SAI LIFE SCIENCES LIMITED
L4- 01 & 02, SLN Terminus Survey,
Survey no. 133, Gachibowli Miyapur Road,
Gachibowli, Hyderabad 500 032, Telangana
Phone:Â +91 40 6815 6000
Email: [email protected]
Website: www.sailife.com
Sai Life Sciences IPO FAQs
How many shares in Sai Life Sciences IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply for Sai Life Sciences Public Offer?
The best way to apply for Sai Life Sciences public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Sai Life Sciences IPO GMP today?
Sai Life Sciences IPO GMP today is INR 70 per share.
What is Sai Life Sciences kostak rate today?
Sai Life Sciences kostak rate today is INR NA per application.
What is Sai Life Sciences Subject to Sauda rate today?
Sai Life Sciences Subject to Sauda rate today is INR 2,800 per application.
